Biofacturing

Cathie Wood-led Ark Invest said on Friday it continues to believe Zymergen Inc (NASDAQ: ZY)’s platform holds deep intrinsic value despite the recent setback and a lowered short-term outlook.  What Happened: Zymergen shares rallied 75% a day after Wood’s firm snapped up shares in...

A bullish Ark Invest on Wednesday more than doubled its stake in Zymergen Inc (NASDAQ: ZY) after it plummeted due to the company’s “immaterial” revenue warning. The Cathie Wood-led New York-based investment management firm snapped up 2.46 million shares, estimated...

Zymergen Inc (NASDAQ: ZY) shares continued to plummet in the pre-market trading on Tuesday. What’s Moving? The synthetic biology company which traded as high as $48.50 after it went public in April, has dived to $11 pre-market hours on Tuesday, far below its initial public offering price...